Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Thom

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|February 28, 2018
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26George Thom, Matthew Burrell, Arsalan S Haqqani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Probing a protein-protein interaction by in vitro evolutionGeorge Thom, Alexis C Cockroft, Andrew G Buchanan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 31, 2018
A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical modelGeorge Thom, Mei-Mei Tian, Jon P Hatcher, et al.
Nature Communications|May 9, 2025
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systemsLouis C Dacquay, Panagiotis Antoniou, Astrid Mentani, et al.
Diabetologia|May 31, 2021
Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)Wilma S Leslie, Eman Ali, Leanne Harris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 14, 2021
Participant experiences in the Diabetes REmission Clinical Trial (DiRECT)Lucia Rehackova, Angela Margarete Rodrigues, George Thom, et al.
Nature Communications|April 9, 2025
Modified pegRNAs mitigate scaffold-derived prime editing by-productsPanagiotis Antoniou, Louis Dacquay, Hanna Mårtensson, et al.
Diabetes, Obesity & Metabolism|December 8, 2020
Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)George Thom, Alasdair McIntosh, Claudia-Martina Messow, et al.
Mabs|April 29, 2010
In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupusYulia Vugmeyster, Heath Guay, Pamela Szklut, et al.
Journal of Chromatography. A|January 16, 2026
Biophysical characterisation of mRNA structure and its impact on integrity analysis by liquid chromatography and capillary gel electrophoresis methodsMayada Elgohary, Alexandra L J Webb, Joseph C Ward, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|February 28, 2018
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26George Thom, Matthew Burrell, Arsalan S Haqqani, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Probing a protein-protein interaction by in vitro evolutionGeorge Thom, Alexis C Cockroft, Andrew G Buchanan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 31, 2018
A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical modelGeorge Thom, Mei-Mei Tian, Jon P Hatcher, et al.
Nature Communications|May 9, 2025
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systemsLouis C Dacquay, Panagiotis Antoniou, Astrid Mentani, et al.
Diabetologia|May 31, 2021
Antihypertensive medication needs and blood pressure control with weight loss in the Diabetes Remission Clinical Trial (DiRECT)Wilma S Leslie, Eman Ali, Leanne Harris, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 14, 2021
Participant experiences in the Diabetes REmission Clinical Trial (DiRECT)Lucia Rehackova, Angela Margarete Rodrigues, George Thom, et al.
Nature Communications|April 9, 2025
Modified pegRNAs mitigate scaffold-derived prime editing by-productsPanagiotis Antoniou, Louis Dacquay, Hanna Mårtensson, et al.
Diabetes, Obesity & Metabolism|December 8, 2020
Weight loss-induced increase in fasting ghrelin concentration is a predictor of weight regain: Evidence from the Diabetes Remission Clinical Trial (DiRECT)George Thom, Alasdair McIntosh, Claudia-Martina Messow, et al.
Mabs|April 29, 2010
In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupusYulia Vugmeyster, Heath Guay, Pamela Szklut, et al.
Journal of Chromatography. A|January 16, 2026
Biophysical characterisation of mRNA structure and its impact on integrity analysis by liquid chromatography and capillary gel electrophoresis methodsMayada Elgohary, Alexandra L J Webb, Joseph C Ward, et al.
Pageof 4